Research & development in the dark: what does it take to make one medicine? And what could it take?

被引：2
|
作者：
Reid, J. [1 ]
Balasegaram, M. [1 ]
机构：
[1] Access Campaign, Doctors Borders Med Sans Frontieres, Geneva, Switzerland
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2016年 / 22卷 / 08期
关键词：
Access to medicines; Cost of research and development; Innovation; Research and development; Transparency;
D O I：
10.1016/j.cmi.2016.06.012
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Earlier this year a series of advertisements appeared in London's Westminster tube stations asking viewers to consider a seemingly simple question, 'what does it take to make one medicine?' But as it turns out, this question is not so simple to answer. In this commentary we highlight some key considerations and questions on what it takes to make one medicine, and what it could take to develop medicines that meet people's health needs and are accessible and affordable for all who need them. J. Reid, (C) 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：655 / 657
页数：3
相关论文
共 50 条
12345